Cytokine storm in COVID-19: immunopathogenesis and therapy

C Zanza, T Romenskaya, AC Manetti, F Franceschi… - Medicina, 2022 - mdpi.com
A cytokine storm is a hyperinflammatory state secondary to the excessive production of
cytokines by a deregulated immune system. It manifests clinically as an influenza-like …

COVID‐19: Virology, biology and novel laboratory diagnosis

M Mohamadian, H Chiti, A Shoghli… - The journal of gene …, 2021 - Wiley Online Library
Background At the end of December 2019, a novel coronavirus tentatively named SARS‐
CoV‐2 in Wuhan, a central city in China, was announced by the World Health Organization …

[HTML][HTML] COVID-19-neutralizing antibodies predict disease severity and survival

WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang… - Cell, 2021 - cell.com
Summary Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …

[HTML][HTML] Spike mutation D614G alters SARS-CoV-2 fitness

JA Plante, Y Liu, J Liu, H Xia, BA Johnson… - Nature, 2021 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein
substitution D614G became dominant during the coronavirus disease 2019 (COVID-19) …

Synthesis and systematic review of reported neonatal SARS-CoV-2 infections

R Raschetti, AJ Vivanti, C Vauloup-Fellous… - Nature …, 2020 - nature.com
A number of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections
have been reported in neonates. Here, we aim to clarify the transmission route, clinical …

Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19

J Davies, HS Randeva, K Chatha… - Molecular …, 2020 - spandidos-publications.com
Infection by the severe acute respiratory syndrome (SARS) coronavirus‑2 (SARS‑CoV‑2) is
the cause of the new viral infectious disease (coronavirus disease 2019; COVID‑19) …

JAK-STAT pathway inhibition and their implications in COVID-19 therapy

S Satarker, AA Tom, RA Shaji, A Alosious… - Postgraduate …, 2021 - Taylor & Francis
As the incidence of COVID-19 increases with time, more and more efforts are made to pave
a way out for the therapeutic strategies to deal with the disease progression. Inflammation …

SARS‐CoV‐2 infection, COVID‐19 pathogenesis, and exposure to air pollution: What is the connection?

B Woodby, MM Arnold… - Annals of the new York …, 2021 - Wiley Online Library
Exposure to air pollutants has been previously associated with respiratory viral infections,
including influenza, measles, mumps, rhinovirus, and respiratory syncytial virus …

Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice

T Brendler, A Al‐Harrasi, R Bauer… - Phytotherapy …, 2021 - Wiley Online Library
In times of health crisis, including the current COVID‐19 pandemic, the potential benefit of
botanical drugs and supplements emerges as a focus of attention, although controversial …

Recent update on the anti-inflammatory activities of propolis

F Zulhendri, R Lesmana, S Tandean, A Christoper… - Molecules, 2022 - mdpi.com
In recent years, research has demonstrated the efficacy propolis as a potential raw material
for pharmaceuticals and nutraceuticals. There is limited report detailing the mechanisms of …